SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumbles Q3 results beat guidance and marked its first adjusted-EBITDA-profitable quarter, with Quake AI and Northern Data driving much of the growth. Traders welcomed the milestone but questioned cash burn, financing needs and potential dilution, tempering the bullish reaction.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves quarterly revenue beat and raised outlook, alongside strong AI-compute demand and a plan to rely more on customer prepayments and secured financing, have fueled a bullish rebound and short-squeeze speculation. Traders remain divided: supporters see the results easing funding concerns, while skeptics point to heavy debt, interest costs, capital spending and uncertain profitability.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigettis weak Q3 results and lower revenue outlook are weighing on shares, with traders questioning its valuation and how long commercialization may take. Others argue that progress on its quantum hardware, cash reserves, and government support justify a longer-term view despite limited current revenue.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Allegations involving Jensen Huang and questions about possible China-linked chip shipments have dominated discussion, with traders debating whether the controversy could bring investigations or leadership and regulatory risksor is separate from Nvidias business. The selloff and Baird downgrade drew bearish reactions, while dip-buyers point to CoreWeaves strong results and Nvidias upcoming earnings as signs of continued AI demand.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ousters quarterly results and outlook are drawing attention, with strong revenue growth and record sensor shipments reinforcing the Physical AI and robotics growth story. Traders are broadly encouraged by the results and Rev8 demand, but debate the outlook and margins, while broader weakness in AI-related stocks adds pressure to the share price.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors deramiocel application for Duchenne muscular dystrophy is in final FDA review ahead of the Nov. 22 decision, with management reaffirming confidence and launch preparations on its Q3 call. Traders are mostly optimistic and discuss potential short-covering, while others stress the binary risk and cite possible FDA concerns or a rejection.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costcos announcement of a record special dividend and renewed share-buyback authorization is driving attention, with many traders welcoming the shareholder payout. Others argue the stock remains expensive and caution that the dividend is not free value to shareholders.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlists Q3 results and conference call are driving attention, with traders focused on Samsung and Micron licensing revenue, improved profitability, and managements outlook for stronger results ahead. Many are bullish on a possible SK Hynix licensing deal after CEO C.K. Hong called it the next logical license, though that remains speculation; others question the earnings expectations, product-sales decline, and sustainability of the results.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

SOXX is drawing attention amid sharp semiconductor volatility as traders debate whether the AI-driven selloff is overdone or signals weaker data-center spending and tougher project economics. Bulls point to continued chip demand and view the rebound as a buying opportunity, while bears cite damaged technicals and lingering uncertainty, including Nvidia-related headlines.

Amentum Holdings, Inc. engages in mission-critical, technology-driven services in government and commercial markets. It operates through the Digital Solutions and Global Engineering Solutions segments. The Digital Solutions segment provides advanced digital and data-driven solutions including intelligence analytics, space system development, cybersecurity, and next generation IT. The Global Engineering Solutions segment manages large-scale environmental remediation, nuclear power solutions, platform engineering, sustainment and supply chain management. The company was founded on November 26, 2019 and is headquartered in Chantilly, VA.

Amentum Holdings Inc.

Amentums recent defense, nuclear and NASA contract wins are drawing attention, but traders are frustrated that the awards have not translated into sustained share-price strength. The community is split between viewing the growing contract backlog and low valuation as a long-term opportunity and questioning the companys growth, margins, debt and management.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$TRDA : Entrada Therapeutics Q3 2026 (reported Nov 5): Cash, equivalents and marketable securities $193.0M at Sept 30; Q3 net loss $39.7M; management runway extended into Q4 2027; ELEVATE-44-201 cohort 1 open-label data expected by year-end 2026; Q3 10-Q discloses substantial doubt about going concern within 12 months. 
 
Questions worth checking: When are the next Entrada TRDA clinical data readouts? How much cash does Entrada Therapeutics have, and how long is it funded? Are Entrada’s Duchenne medicines FDA approved? 
 
Answers, primary sources and downloadable PDF report in our hub: https://www.merlintrader.com/entrada-therapeutics-trda-stock-hub/?utm_source=stocktwits&amp;utm_medium=social&amp;utm_campaign=trda_hubpdf_nov26  
 
Not investment advice.

Entrada stock news: Q3 2026 cash of $193M, net loss $39.7M and runway into Q4 2027, with four clinical readouts scheduled through the first half of 2027.

Merlintrader Trading Pub

TRDA Stock: Entrada Therapeutics News

StockTwits Web

Entrada Therapeutics Inc

 : Entrada Therapeutics Q3 2026 (reported Nov 5): Cash, equivalents and marketable securities $193.0M at Sept 30; Q3 net loss $39.7M; management runway extended into Q4 2027; ELEVATE-44-201 cohort 1 open-label data expected by year-end 2026; Q3 10-Q discloses substantial doubt about going concern within 12 months. 
 
Questions worth checking: When are the next Entrada TRDA clinical data readouts? How much cash does Entrada Therapeutics have, and how long is it funded? Are Entrada’s Duchenne medicines FDA approved? 
 
Answers, primary sources and downloadable PDF report in our hub: 